The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.

Rare Disease Day at IndoUSrare - Bridging Nations, Empowering RARE Lives Dr. Harsha Rajasimha with Jenifer Waldrop at the RDDC RISE Awards ...

According to a report from Reuters, several employees at the US Food and Drug Administration who were tasked with managing reviews and applications related to Musk’s Neuralink received pink ...

Whether it’s Ozempic, Pilates, or sheer will, celebrity transformations take all shapes and sizes - so what's the hassle all ...

Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...

This $330 smartwatch can outlast its competitors in battery life and fitness features, but may fall short on software updates ...

ADIA Nutrition Inc. (OTC Pink: ADIA), a pioneer in healthcare innovation and regenerative medicine, concludes an extraordinary February with ...

Bird flu. With that diagnosis in mind, one of Russo’s colleagues tried to get some bovine samples tested for H5N1, but the ...

UB hosted a Rare Disease Day program at the Jacobs School of Medicine and Biomedical Sciences to raise awareness of rare diseases.

CHINO HILLS, CA / ACCESS Newswire / March 10, 2025 / SOHM, Inc. (OTC PINK:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, has announced today ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (previously NYSE American: KNW, now OTC Pink Markets ... through KTL may not require such prior FDA approval. Safe Harbor Statement This release contains ...